scorecardresearch
Add as a preferred source on Google
Wednesday, November 5, 2025
TopicPharmaceutical industry

Topic: Pharmaceutical industry

Govt gives Rs 15,000-cr boost to API and devices industry to check shortage amid COVID-19

The government hasn’t yet announced details of the policy, which seeks to make India self-reliant in the manufacturing of bulk drugs.   

India could ‘withdraw’ curbs on drug exports as pharma firms fear loss of business

In a meeting with govt officials, drug-makers flagged concerns that their clients may start buying products from other countries if restrictions on Indian products continued.

Shaken by coronavirus crisis, India looks to become bulk drugs major to cut China imports

Despite being the leading supplier of medicines across the globe, Indian pharma industry heavily depends on China for ingredients used to make even basic drugs.

India lists 38 drug raw materials for which it wants to end dependence on China 

In meeting chaired by Niti Aayog CEO Amitabh Kant, govt asks top Indian pharma firms to amp up production of these 38 raw materials, technically called APIs.

India’s supply of these medicines could be hurt by China’s coronavirus crisis

In a list sent to the Modi govt, pharma firms have said they could run short of 57 medicines if China shutdown continues due to coronavirus outbreak.

Pharma firms want govt to tweak ethics code, allow free samples, ‘educational’ foreign trips 

The proposal, criticised by patient-health activists, has been prepared by drug firms through the Indian Pharmaceutical Alliance.

Pharma group denies PM Modi had warned companies against unethical marketing

ThePrint had reported that PM Modi told pharma companies to stop bribing doctors. IPA secy general had said he didn’t have any information about such a meeting.

Modi govt plans action against US writer who said Indian drugs are ‘flea-market quality’

In her May 2019 book Bottle of Lies, Katherine Eban accused Indian pharma firms of major lapses such as ‘toxic impurities’ and fudging data on quality control.  

India’s price control policy has destroyed drug manufacturers. This is how they can be saved

India has one of the lowest drug prices in the world, yet many Indians are deprived of life-saving drugs. Price controls haven't been enough to bridge this gap.

Capping profits will wipe out low-cost generic medicines, drugmakers write to PM Modi

Trade bodies representing MSMEs write to PM after big players agreed to Modi govt’s proposal to cap trade margins for all medicines at 30% of MRP.

On Camera

Indians have a complicated relationship with Zohran Mamdani

Mamdani’s politics feels unusual compared to India’s current climate. He unapologetically foregrounds Muslim identity at a time when doing so in India invites scrutiny.

What does NCLAT order mean for data-sharing ban, penalty imposed by CCI on Meta & WhatsApp

On 4 November 2025, NCLAT bench, comprising Chairperson Justice Ashok Bhushan and Member Arun Baroka, noted that WhatsApp and Meta are distinct legal entities.

‘Let them see’: Putin says new nuclear-powered missiles in the making, in message to Washington

At a ceremony felicitating Russian military engineers, Putin highlights Moscow’s 'parity' in defence technologies for the next century.

Trump’s trade wars have rewritten powerplay, but India didn’t get the memo

This world is being restructured and redrawn by one man, and what’s his power? It’s not his formidable military. It’s trade. With China, it turned on him.